Capstone Advisors focuses on acquiring, developing, and managing commercial and residential real estate.

Capstone Advisors

Kalderos aims to bring clarity and transparency to the complex world of drug discounts, facilitating the smooth operation of discount programs and ensuring funds flow seamlessly as intended to support safety-net providers, manufacturers, and patient access to care and treatments.

Kalderos

Neuro Vigor Therapeutics is a development stage company focused on reducing reactive aldehyde species, which are significant contributors to multiple diseases, trauma, and pain.

Neuro Vigor Therapeutics

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

H. Lundbeck A/S

Lundbeck focuses exclusively on brain diseases, specializing in the development and commercialization of therapies for conditions such as Alzheimer's, depression, and schizophrenia. It has over 70 years of neuroscience expertise.

Metric
Company Name	Capstone Advisors	Kalderos	Neuro Vigor Therapeutics
Symbol
MSH ID	COM:CAPSTONEADVISORS	COM:KALDEROS	COM:NVTHERAPEUTICS
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Real Estate	Healthcare & Health Services	Healthcare & Health Services
Industry	Commercial Real Estate	Healthcare & Health Services	Biotechnology
Country	US		US
Stage
Employee Count		51
Website	capstoneadvisors.com	kalderos.com	nvtherapeutics.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:LUNDBECK

Lundbeck

Last Close

171.10

01/01 00:00

Volume Today

346.95K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue